ONCOLYTICS BIOTECH INC. ANNOUNCES ISSUANCE OF THIRD CANADIAN PATENT

Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") has been granted Canadian Patent 2,283,280 entitled "Reovirus for the treatment of neoplasia." The claims describe the use of a reovirus for the manufacture of a medicament to treat Ras-mediated neoplasia as well as methods of treating various cancers by the administration of the reovirus.

Yahoo News (http://biz.yahoo.com/prnews/051020/to282.html?.v=13)